カテゴリー： QYResearch, 世界

胆嚢癌療法の世界市場：規模・現状・予測

QYResearchが発行した調査報告書（DATA909X18497）
◆英語タイトル：Global Gallbladder Cancer Therapeutics Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18497
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※当調査レポートでは、胆嚢癌療法の世界市場について調査・分析し、胆嚢癌療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、医学研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の胆嚢癌療法市場動向
・主要企業別マーケットシェア
・胆嚢癌療法の種類別市場規模2014-2019
（併用療法、単剤療法）
・胆嚢癌療法の用途別市場規模2014-2019
（病院、医学研究所、クリニック、その他）
・胆嚢癌療法の北米市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法のヨーロッパ市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法の中国市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法の日本国内市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法の東南アジア市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法のインド市場：主要企業・種類別/用途別市場規模
・胆嚢癌療法の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Bristol-Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Pfizer Inc.、Sanofi.）
・胆嚢癌療法の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition.Surgery is considered the primary treatment approach for gallbladder cancer, which involves the complete removal of the organ. However, the second line of treatment involves the use of radiation therapy along with chemotherapeutics. The rising availability of financial assistance programs is further helping patients in availing these high-cost treatments. With the increasing occurrence of these risk factors, the need for gallbladder cancer therapeutics will subsequently increase over the forecast period.
In 2018, the global Gallbladder Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gallbladder Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gallbladder Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Bristol-Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
Sanofi.
…

Market segment by Type, the product can be split into
Combination Therapy
Monotherapy

Market segment by Application, split into
Hospital
Medical Research Institute
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gallbladder Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gallbladder Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gallbladder Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gallbladder Cancer Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Combination Therapy
1.4.3 Monotherapy
1.5 Market by Application
1.5.1 Global Gallbladder Cancer Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Clinic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gallbladder Cancer Therapeutics Market Size
2.2 Gallbladder Cancer Therapeutics Growth Trends by Regions
2.2.1 Gallbladder Cancer Therapeutics Market Size by Regions (2019-2025)
2.2.2 Gallbladder Cancer Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Gallbladder Cancer Therapeutics Market Size by by Players
3.1.1 Global Gallbladder Cancer Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Gallbladder Cancer Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Gallbladder Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gallbladder Cancer Therapeutics Key Players Head office and Area Served
3.3 Key Players Gallbladder Cancer Therapeutics Product/Solution/Service
3.4 Date of Enter into Gallbladder Cancer Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gallbladder Cancer Therapeutics Market Size by Type (2014-2019)
4.2 Global Gallbladder Cancer Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Gallbladder Cancer Therapeutics Market Size (2014-2019)
5.2 Gallbladder Cancer Therapeutics Key Players in North America
5.3 North America Gallbladder Cancer Therapeutics Market Size by Type
5.4 North America Gallbladder Cancer Therapeutics Market Size by Application

6 Europe
6.1 Europe Gallbladder Cancer Therapeutics Market Size (2014-2019)
6.2 Gallbladder Cancer Therapeutics Key Players in Europe
6.3 Europe Gallbladder Cancer Therapeutics Market Size by Type
6.4 Europe Gallbladder Cancer Therapeutics Market Size by Application

7 China
7.1 China Gallbladder Cancer Therapeutics Market Size (2014-2019)
7.2 Gallbladder Cancer Therapeutics Key Players in China
7.3 China Gallbladder Cancer Therapeutics Market Size by Type
7.4 China Gallbladder Cancer Therapeutics Market Size by Application

8 Japan
8.1 Japan Gallbladder Cancer Therapeutics Market Size (2014-2019)
8.2 Gallbladder Cancer Therapeutics Key Players in Japan
8.3 Japan Gallbladder Cancer Therapeutics Market Size by Type
8.4 Japan Gallbladder Cancer Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gallbladder Cancer Therapeutics Market Size (2014-2019)
9.2 Gallbladder Cancer Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gallbladder Cancer Therapeutics Market Size by Type
9.4 Southeast Asia Gallbladder Cancer Therapeutics Market Size by Application

10 India
10.1 India Gallbladder Cancer Therapeutics Market Size (2014-2019)
10.2 Gallbladder Cancer Therapeutics Key Players in India
10.3 India Gallbladder Cancer Therapeutics Market Size by Type
10.4 India Gallbladder Cancer Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gallbladder Cancer Therapeutics Market Size (2014-2019)
11.2 Gallbladder Cancer Therapeutics Key Players in Central & South America
11.3 Central & South America Gallbladder Cancer Therapeutics Market Size by Type
11.4 Central & South America Gallbladder Cancer Therapeutics Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb Co.
12.1.1 Bristol-Myers Squibb Co. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gallbladder Cancer Therapeutics Introduction
12.1.4 Bristol-Myers Squibb Co. Revenue in Gallbladder Cancer Therapeutics Business (2014-2019))
12.1.5 Bristol-Myers Squibb Co. Recent Development
12.2 Eli Lilly and Co.
12.2.1 Eli Lilly and Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gallbladder Cancer Therapeutics Introduction
12.2.4 Eli Lilly and Co. Revenue in Gallbladder Cancer Therapeutics Business (2014-2019)
12.2.5 Eli Lilly and Co. Recent Development
12.3 F. Hoffmann-La Roche Ltd.
12.3.1 F. Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gallbladder Cancer Therapeutics Introduction
12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Gallbladder Cancer Therapeutics Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
12.4 Pfizer Inc.
12.4.1 Pfizer Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gallbladder Cancer Therapeutics Introduction
12.4.4 Pfizer Inc. Revenue in Gallbladder Cancer Therapeutics Business (2014-2019)
12.4.5 Pfizer Inc. Recent Development
12.5 Sanofi.
12.5.1 Sanofi. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gallbladder Cancer Therapeutics Introduction
12.5.4 Sanofi. Revenue in Gallbladder Cancer Therapeutics Business (2014-2019)
12.5.5 Sanofi. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gallbladder Cancer Therapeutics Key Market Segments
Table Key Players Gallbladder Cancer Therapeutics Covered
Table Global Gallbladder Cancer Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Combination Therapy Figures
Table Key Players of Combination Therapy
Figuer Monotherapy Figures
Table Key Players of Monotherapy
Table Global Gallbladder Cancer Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Gallbladder Cancer Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Medical Research Institute Case Studies
Figure Clinic Case Studies
Figure Other Case Studies
Figure Gallbladder Cancer Therapeutics Report Years Considered
Figure Global Gallbladder Cancer Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Gallbladder Cancer Therapeutics Market Share by Regions 2014-2019
Figure Global Gallbladder Cancer Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Gallbladder Cancer Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Share by by Players (2014-2019)
Figure Global Gallbladder Cancer Therapeutics Market Share by by Players in 2018
Table Global Gallbladder Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gallbladder Cancer Therapeutics Product/Solution/Service
Table Date of Enter into Gallbladder Cancer Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gallbladder Cancer Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gallbladder Cancer Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gallbladder Cancer Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gallbladder Cancer Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gallbladder Cancer Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gallbladder Cancer Therapeutics Revenue Market Share by Application in 2018
Figure North America Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table North America Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table North America Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure Europe Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table Europe Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table Europe Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure China Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table China Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table China Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table China Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table China Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure Japan Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table Japan Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Japan Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table Japan Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Japan Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure Southeast Asia Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table Southeast Asia Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table Southeast Asia Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure India Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table India Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table India Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table India Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table India Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Figure Central & South America Gallbladder Cancer Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gallbladder Cancer Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gallbladder Cancer Therapeutics Market Share (2018-2019)
Table Central & South America Gallbladder Cancer Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Gallbladder Cancer Therapeutics Market Share by Type 2014-2019
Table Central & South America Gallbladder Cancer Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Gallbladder Cancer Therapeutics Market Share by Application 2014-2019
Table Bristol-Myers Squibb Co. Company Details
Table Bristol-Myers Squibb Co. Revenue in Gallbladder Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Co. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Co. Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Revenue in Gallbladder Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Eli Lilly and Co. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2014-2019)
Table Eli Lilly and Co. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Gallbladder Cancer Therapeutics Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Gallbladder Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Sanofi. Company Details
Table Sanofi. Revenue in Gallbladder Cancer Therapeutics Business 2014-2019 (Million US$)
Figure Sanofi. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2014-2019)
Table Sanofi. Recent Development
Table Global Gallbladder Cancer Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gallbladder Cancer Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gallbladder Cancer Therapeutics Market Size Share by Regions in 2025
Figure North America Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gallbladder Cancer Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gallbladder Cancer Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gallbladder Cancer Therapeutics Market Size by Product (2019-2025)
Figure Global Gallbladder Cancer Therapeutics Market Size by Product in 2025
Table Global Gallbladder Cancer Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gallbladder Cancer Therapeutics Market Size by Application (2019-2025)
Figure Global Gallbladder Cancer Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bristol-Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Pfizer Inc.、Sanofi.

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 胆嚢癌療法の世界市場：規模・現状・予測(Global Gallbladder Cancer Therapeutics Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測
  • 世界の機械加工ミストコレクター産業：成長傾向・競合分析
  • 世界のリチウムイオンエネルギー蓄電池産業：成長傾向・競合分析
  • 世界の聴衆反応キーパッド産業：成長傾向・競合分析
  • 世界のトラクショントランス市場
  • 世界の信号灯市場
  • 世界のポータブルヒーター市場
  • 世界のナノファイバー市場
  • 世界のN,N,N’-トリメチルアミノエチルエタノールアミン（TMAEEA）市場
  • 世界のイソプロテレノール市場
  • 世界の道路標示用ガラスビーズ市場
  • 世界のドーザー機械制御システム市場
  • 世界の炭素繊維布市場
  • 世界のアルミ鋳造製品市場
  • 世界のオールマウンテンスキー市場